Downregulation of the protein expression of survivin, X chromosome-linked inhibitor of apoptosis (XIAP), proliferating cell nuclear antigen (PCNA), iNOS and COX-2 and increased apoptotic activity suggested that TSL therapy might aid the prevention of oral cancer [86]. The gene discussed is PCNA; the disease is lip and oral cavity carcinoma.